Chronic Lymphocytic Leukaemia: "an overview" &... - CLL Support

CLL Support

22,616 members38,845 posts

Chronic Lymphocytic Leukaemia: "an overview" & A look at the future of CLL treatment: "New treatment options". Dr George Follows - June 2014

HAIRBEAR_UK profile image
HAIRBEAR_UKFounder Admin
8 Replies

The following video/webcasts were produced in Cambridge June 2014 from talks by Dr George Follows of Cambridge University Teaching Hospitals NHS Foundation Trust

Part 1- Chronic Lymphocytic Leukaemia; an overview In this talk Dr Follows explains for patients/carers much about CLL and where we are today in the UK.

sayansho.com/embed/iframe_c...

Part 2 - A look at the future of CLL treatment: New treatment options. In this more scientific talk Dr Follows addresses latest developments and new treatment options and the new landscape.

sayansho.com/embed/iframe_c...

Q&A sessions soon to follow, with webcasts of CLL Nurse specialist talks and interviews with patient advocates.

Nick

cllsupport.org.uk

Written by
HAIRBEAR_UK profile image
HAIRBEAR_UK
Founder Admin
To view profiles and participate in discussions please or .
8 Replies
Mikey47 profile image
Mikey47

Thanks Nick, looking forward to the Q & A.

andrewschorr profile image
andrewschorr

He explains things so clearly. I love this guy!

andrewschorr profile image
andrewschorr

Nick, thanks for your devotion to make this content available worldwide.

HAIRBEAR_UK profile image
HAIRBEAR_UKFounder Admin in reply to andrewschorr

Hi Andrew and everyone

The links to both George Follows talks have been updated and released to include the Cambridge meeting details. (now pinned)

These will be accompanied very soon with The Q&A's which you chaired for us and the CLL nurse specialist talks will then follow .

Revised links:

Part 1- Chronic Lymphocytic Leukaemia; an overview In this talk Dr Follows of Cambridge University hospitals explains for patients/carers much about CLL and where we are today in the UK.

watch here: sayansho.com/embed/iframe_c...

Part 2 - A look at the future of CLL treatment: New treatment options. In this more scientific talk Dr Follows of Cambridge University hospitals addresses latest developments and new treatment options and the new landscape.

watch here: sayansho.com/embed/iframe_c...

Many thanks

Nick

SycamoreN profile image
SycamoreN

Thanks for posting this, Nick. Very informative

Psmithuk profile image
Psmithuk

What an approachable man - I just kept wanting to push his glasses up on his nose.......

thanks for the links

PaulaS profile image
PaulaSVolunteer

I thought the same re his glasses, chrigranny - especially in the second clip :-) But it was great to listen to someone who spoke so clearly and with such humanity and balance.

Thanks Nick, for getting it recorded and posted - and thanks to Dr Follows too of course.

Paula

Kwenda profile image
Kwenda

A wonderfully clear presentation, and a natural born lecturer to fully explain our CLL.

Even the section on the new drugs was presented so that the unscientific can get an understanding of how they work.

These videos should be pinned for the newly diagnosed to watch, and recommended to GP’s …

The benefit of the internet is that the videos can be watched again and again, so that the patient can absorb the information at their own speed.

Thanks

Dick

You may also like...

Interesting recently published overview of Chronic Lymphocytic Leukaemia and Hairy-Cell Leukaemia

published six page overview of Chronic Lymphocytic Leukaemia and Hairy-Cell Leukaemia October...

Dr George Follows and your CLL questions

about CLL and news for patients: Drs. Jeff Sharman, Phil Thompson, Tom Kipps (invited) and George...

A New Era is Coming up in the Treatment of Chronic Lymphocytic Leukemia

interesting overview from Italy The survival of patients with chronic lymphocytic leukemia...

Dr Sharman's survey to assess the CLL community's understanding of new treatments is now closed

an eye on his site for new articles inspired by the survey responses here: http://www.cll-nhl.com...

Health Canada approves Ibrutinib plus Rituximab for First Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)

s-rituximab-for-the-treatment-of-patients-with-chronic-lymphocytic-leukemia-cll--834973397.html Now